SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CYTC - How High Can It Go!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ted Downs who wrote (45)9/30/1997 8:54:00 AM
From: Chuck. Edwards   of 185
 
The mention was in the Wall Street Journal's Monday article on a small cap conference. The person you are quoting is Garret Van Wagoner, the once-hot fund manager of the Van Wagoner funds. (Like many small-cap growth investors, he's gotten hammered during the big-cap rally of the past year.)

I am a long-term investor and like this stock. Thin-prep's results were termed "significantly" better than traditional tests in a major article in the leading gynecology journal. The term "significant" has precise statistical meaning in science, and essentially means that the results cannot be the result of chance -- there is a real, verifiable effect. Since we are talking about a test that can save a "significant" number of lives, the insurance companies will have to come around. At some point, Thin-Prep will become the standard, and anyone who DOESN'T use it will be vulnerable to claims of poor care. Then, watch the cascade of orders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News